calcium phosphate, dibasic, anhydrous has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brancaccio, D; Gallieni, M; Panichi, V; Tetta, C | 1 |
| Bajpai, PK; Benghuzzi, HA; England, BG | 1 |
1 review(s) available for calcium phosphate, dibasic, anhydrous and Cardiovascular Diseases
| Article | Year |
|---|---|
Inflammation, CRP, calcium overload and a high calcium-phosphate product: a "liaison dangereuse".
Topics: C-Reactive Protein; Calcinosis; Calcium; Calcium Phosphates; Cardiovascular Diseases; Humans; Inflammation | 2002 |
1 other study(ies) available for calcium phosphate, dibasic, anhydrous and Cardiovascular Diseases
| Article | Year |
|---|---|
Controlled release of hydrophilic compounds by resorbable and biodegradable ceramic drug delivery devices.
Topics: Biodegradation, Environmental; Biological Products; Calcium Phosphates; Cardiovascular Diseases; Ceramics; Delayed-Action Preparations; Drug Delivery Systems; Durapatite; Epinephrine; Humans; Hydroxyapatites; Minerals | 1992 |